Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Nanfang Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥4.4

2024-10-29

Market Capitalization

¥1.2 B

2024-10-29

Revenue

¥592.6 M

FY, 2025

CreditSafe Score

?
Score changed on Jul 19, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue474.5M486.5M1.1B519.4M539.1M592.7M595.3M592.6M
Cost of goods sold367.3M385.7M709.1M418.2M473.2M544.4M616.7M577.1M
Gross profit107.5M101.9M353.1M104.9M66.5M48.7M(20.8M)16.3M
Gross profit margin, %21.0%33.3%20.2%12.3%8.2%-3.5%2.8%
Operating expense total60.7M52.3M182.6M83.9M50.0M41.8M81.7M43.8M
Depreciation and amortization19.2M13.2M36.4M31.4M41.2M88.4M88.4M44.9M
EBITDA46.7M49.5M176.7M27.9M23.8M14.8M(94.3M)(18.3M)
EBITDA margin, %10.2%16.7%5.4%4.4%2.5%-15.8%-3.1%
EBIT34.2M29.2M119.7M(23.7M)(23.9M)(134.7M)(182.0M)(80.9M)
EBIT margin, %6.0%11.3%-4.6%-4.4%-22.7%-30.6%-13.7%
Interest income6.6M2.8M2.2M1.2M2.0M1.2M467.0K63.0K
Interest expense7.0M6.6M7.6M11.8M20.2M23.2M26.4M21.7M
Pre tax profit44.6M28.1M109.9M(30.7M)(29.3M)(148.5M)(200.9M)(93.1M)
Income tax expense7.8M2.9M11.6M(7.6M)(14.4M)(1.2M)(10.4M)8.0M
Net Income36.8M25.2M98.3M(23.0M)(14.9M)(147.3M)(190.5M)(101.1M)

Footer menu